China SXT Pharmaceuticals Inc. (NASDAQ:SXTC) went up by 22.22% from its latest closing price compared to the recent 1-year high of $45.60. The company’s stock price has collected 25.90% of gains in the last five trading sessions.
Is It Worth Investing in China SXT Pharmaceuticals Inc. (NASDAQ :SXTC) Right Now?
Plus, the 36-month beta value for SXTC is at 0.56.
SXTC currently public float of 2.94M and currently shorts hold a 2.34% ratio of that float. Today, the average trading volume of SXTC was 324.52K shares.
SXTC’s Market Performance
SXTC stocks went up by 25.90% for the week, with a monthly jump of 10.00% and a quarterly performance of -56.09%, while its annual performance rate touched -92.48%. The volatility ratio for the week stands at 12.68% while the volatility levels for the past 30 days are set at 11.54% for China SXT Pharmaceuticals Inc. The simple moving average for the period of the last 20 days is 14.29% for SXTC stocks with a simple moving average of -78.27% for the last 200 days.
SXTC Trading at -28.30% from the 50-Day Moving Average
After a stumble in the market that brought SXTC to its low price for the period of the last 52 weeks, the company was unable to rebound, for now settling with -95.42% of loss for the given period.
Volatility was left at 11.54%, however, over the last 30 days, the volatility rate increased by 12.68%, as shares surge +15.47% for the moving average over the last 20 days. Over the last 50 days, in opposition, the stock is trading -54.57% lower at present.
During the last 5 trading sessions, SXTC rose by +25.90%, which changed the moving average for the period of 200-days by -90.67% in comparison to the 20-day moving average, which settled at $1.8400. In addition, China SXT Pharmaceuticals Inc. saw -83.93% in overturn over a single year, with a tendency to cut further losses.
Stock Fundamentals for SXTC
Current profitability levels for the company are sitting at:
- -36.18 for the present operating margin
- +59.43 for the gross margin
The net margin for China SXT Pharmaceuticals Inc. stands at -57.52. The total capital return value is set at -10.76, while invested capital returns managed to touch -21.63. Equity return is now at value -50.10, with -28.10 for asset returns.
Based on China SXT Pharmaceuticals Inc. (SXTC), the company’s capital structure generated 0.27 points at debt to equity in total, while total debt to capital is 0.27. Total debt to assets is 0.13, with long-term debt to equity ratio resting at 0.04. Finally, the long-term debt to capital ratio is 0.04.
When we switch over and look at the enterprise to sales, we see a ratio of -4.92, with the company’s debt to enterprise value settled at 0.00. The receivables turnover for the company is 0.52 and the total asset turnover is 0.17. The liquidity ratio also appears to be rather interesting for investors as it stands at 1.22.